A Harris administration would be detrimental to biomedical innovation ...Middle East

America is the world leader in biomedical innovation. And a Kamala Harris administration represents an existential threat to that discovery and innovation, which will cost lives and jobs. Innovation has long been driven by robust intellectual property protections, strong federal investments in medical research funding and supportive tax and regulatory policies. America produces nearly twice as many drugs as our European counterparts and nearly four times as many as Japan. This leadership has not only resulted in groundbreaking advancements in medicine, but also provided Americans with unprecedented access to new drugs. Between 2015 and 2021, 74 percent of novel active ingredients were

Hence then, the article about a harris administration would be detrimental to biomedical innovation was published today ( Sunday 01/09/2024 - 11:33 PM ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( A Harris administration would be detrimental to biomedical innovation )

Also on site :

• Ukraine will try “to get some concessions” from Trump at meeting
• Getting hired in 2026 is all about your ‘microcredentials’ says CEO of $1.3 billion learning platform—this is what he tells Gen Z to focus on
• Teens arrested after large disturbance, multiple fights at Joliet mall